Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis

Kevin G. Friedman(Boston Children's Hospital), Jane W. Newburger(Oregon Health & Science University), Thomas Giorgio(Boston Children's Hospital), Sarah D. de Ferranti, Kimberlee Gauvreau(Boston Children's Hospital), Annette Baker(Boston Children's Hospital), Mary Beth F. Son(Boston Children's Hospital), Robert P. Sundel(Boston Children's Hospital), Audrey Dionne(Boston Children's Hospital)
Archives of Disease in Childhood
September 17, 2020
10.1136/archdischild-2020-319810
Cited by 39

Related Papers

Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
|Circulation|2019|6.2k
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
Prevention of Infective Endocarditis
|Circulation|2007|2.8k
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k